XENE – xenon pharmaceuticals inc. - common shares (US:NASDAQ)
Stock Stats
News
3/16
08:43 am
xene
Low
Xenon Pharmaceuticals (XENE) had its price target lowered by Wedbush from $64.00 to $63.00. They now have an "outperform" rating on the stock.
3/15
05:47 am
xene
Low
Xenon Pharmaceuticals (XENE) Climbs 31.7% as Epilepsy Treatment Moves Forward [Yahoo! Finance]
3/12
10:04 pm
xene
Medium
Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters' Option to Purchase Additional Shares [Yahoo! Finance]
3/12
07:06 pm
xene
Medium
Assessing Xenon Pharmaceuticals (XENE) Valuation After A Sharp Recent Share Price Surge [Yahoo! Finance]
3/12
04:01 pm
xene
Medium
Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
2/26/2026
04:01 pm
XENE
-3.8%
MISS
11/3/2025
04:01 pm
XENE
-4.9%
BEAT
8/11/2025
04:01 pm
XENE
5.5%
BEAT
5/12/2025
04:01 pm
XENE
-17.4%
BEAT
3/16
08:27 am
Maintains
Outperform
Outperform
Wedbush
Low
-1.3%
3/16
08:27 am
Maintains
Outperform
Outperform
Wedbush
Low
-1.3%
3/10
09:04 am
Maintains
Overweight
Overweight
Wells Fargo
Low
-2.6%
3/10
09:04 am
Maintains
Overweight
Overweight
Wells Fargo
Low
-2.6%
3/10
08:25 am
Maintains
Outperform
Outperform
Wedbush
Low
-1.4%
3/13
08:17 pm
xene
Low
Form 4 Xenon Pharmaceuticals For: Mar 12 Filed by: DiFabio Andrea
3/13
08:17 pm
xene
Low
Form 4 Xenon Pharmaceuticals For: Mar 12 Filed by: KENNEY CHRISTOPHER JOHN
3/13
08:16 pm
xene
Low
Form 4 Xenon Pharmaceuticals For: Mar 12 Filed by: MORTIMER IAN
3/13
07:51 pm
xene
Low
Form 144 Xenon Pharmaceuticals Filed by: KENNEY CHRISTOPHER JOHN
3/13
07:50 pm
xene
Low
Form 144 Xenon Pharmaceuticals Filed by: MORTIMER IAN
Show more
Top News Gainers
3/9 Xenon Pharmaceuticals, Inc. (XENE) CEO Simon Pimstone on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] 6.5%
1/14 Xenon Pharmaceuticals Inc (NASDAQ: XENE) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. 6.2%
1/10 Form 8-K Xenon Pharmaceuticals For: Jan 08 5.6%
12/3 Xenon Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference 5.2%
3/2 Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss 2019 Financial Results and Provide Corporate Update 5.1%
12/11 Form SC 13D Xenon Pharmaceuticals Filed by: NEUROCRINE BIOSCIENCES INC 4.7%
12/2 Neurocrine Biosciences and Xenon Pharmaceuticals Announce Agreement to Develop First-in-Class Treatments for Epilepsy 4.1%
3/31 Xenon Pharmaceuticals Provides Corporate Update in the Context of COVID-19 3.9%
2/4 Xenon Pharmaceuticals Inc (NASDAQ: XENE) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. 3.0%
1/8 Xenon Pharmaceuticals Inc (NASDAQ: XENE) is now covered by analysts at William Blair. They set an "outperform" rating on the stock. 2.6%
Top News Decliners
12/2 Form 8-K Xenon Pharmaceuticals For: Dec 02 -12.3%
3/11 Form 8-K Xenon Pharmaceuticals For: Mar 11 -8.9%
1/22 Xenon Pharmaceuticals Announces Proposed Public Offering of Common Shares -7.0%
3/13 Form 8-K Xenon Pharmaceuticals For: Mar 12 -6.4%
9/25 Xenon Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference -4.8%
12/5 Xenon Pharmaceuticals Inc (NASDAQ: XENE) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -4.3%
12/5 Xenon Pharmaceuticals (XENE) Investor Presentation - Slideshow [Seeking Alpha] -4.3%
2/13 Form SC 13G/A Xenon Pharmaceuticals Filed by: Vivo Opportunity, LLC -4.0%
3/26 Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) -3.9%
4/28 Form DEF 14A Xenon Pharmaceuticals For: Jun 01 -2.6%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3